PMEL and neoplasm: Indeed, due to its high mutational load as well as the presence of tumor-associated antigens (as gp100, tyrosinase, and Melan-A) that can elicit immune system activation, SKCM is considered one of the best targets in the field of anti-tumor immunotherapy [3, 4].